Explore
← New search
12 matching publication(s)
Integration of Transcriptomics With Interpretable Artificial Intelligence for Identifying Molecular Signatures of Physiological Stress in Sleep Deprivation.
PMID 42216239 · J Cell Mol Med · 2026
L1
49/100
Prognostic biomarker discovery in pancreatic cancer through hybrid ensemble feature selection and multi-omics data.
PMID 41957754 · BioData Min · 2026
L1
92/100
Spatial transcriptomics reveals the molecular signatures of prodromal and advanced α-synucleinopathy.
PMID 41736854 · iScience · 2026
L1
70/100
DMN-seq enriches DNA hypomethylated regions for biomarker discovery using 5-methylcytosine glycosylase.
PMID 41673887 · Genome Biol · 2026
L1
80/100
Investigating epigenetic biomarkers of age, sex, and disease in captive South African cheetahs (Acinonyx jubatus jubatus).
PMID 41528985 · PLoS One · 2026
L1
58/100
Interpretable artificial intelligence based on immunoregulation-related genes predicts prognosis and immunotherapy response in lung adenocarcinoma.
PMID 41048340 · Front Bioinform · 2025
L1
71/100
Comprehensive bioinformatics analysis and experimental verification identify mitochondrial gene Dgat2 as a novel therapeutic biomarker for myocardial ischemia-r
PMID 40510478 · Front Endocrinol (Lausanne) · 2025
L1
64/100
scATD: a high-throughput and interpretable framework for single-cell cancer drug resistance prediction and biomarker identification.
PMID 40501071 · Brief Bioinform · 2025
L1
62/100
Dynamic Gene Attention Focus (DyGAF): Enhancing Biomarker Identification Through Dual-Model Attention Networks.⚑
PMID 40160891 · Bioinform Biol Insights · 2025
L1
44/100
⚑
Revealing the critical state and identifying individualized dynamic network biomarker for type 2 diabetes through advanced analysis methods on individual basis.
PMID 39890881 · Sci Rep · 2025
L1
75/100
Enhancing chemotherapy response prediction via matched colorectal tumor-organoid gene expression analysis and network-based biomarker selection.
PMID 39754813 · Transl Oncol · 2025
L1
78/100
Molecular Biomarker of Drug Resistance Developed From Patient-Derived Organoids Predicts Survival of Colorectal Cancer Patients.
PMID 35425715 · Front Oncol · 2022
L1
53/100